Form 4: Elanco Animal Health Executive Grace McArdle Reports Stock Transactions
SEC Form 4 Filing
EVP Grace McArdle reports acquisition of 2,033 shares and disposal of 1,089 shares of Elanco Animal Health Inc. stock.
Summary
- Grace McArdle, EVP of Manufacturing and Quality at Elanco Animal Health Inc., filed a Form 4 on February 29, 2024.
- The report details changes in her beneficial ownership of Elanco's common stock.
- On February 27, 2024, McArdle acquired 2,033 shares at $0 and disposed of 1,089 shares at $16.46.
- Following these transactions, McArdle directly owns 42,636 shares of Elanco common stock.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to stock transactions by a company executive. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date of stock transactions (acquisition and disposal). |
| 02/29/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.